About Compendia Bioscience
Compendia Bioscience was founded in 2006 in Ann Arbor, United States, within the bioscience sector. Genomic data and analysis tools are provided for biomarker and gene target identification, primarily in oncology. Operations include web applications such as Oncomine editions for cancer profiling, OncoScore for patient stratification in clinical trials, OncoPredictor tools for biomarker evaluation across preclinical and clinical populations, and solutions for target validation through genomic aberrations and expression analysis.
- Headquarter Ann Arbor, United States
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
$2.4 M (USD), Grant
Oct 11, 2007
-
Investors
Life Technologies
& 1 more
-
Employee Count
Not available
-
Acquired by
Life Technologies
(Oct 08, 2012)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Compendia Bioscience
Investors in Compendia Bioscience
Compendia Bioscience has secured backing from 2 investors, including venture fund and institutional investors. Prominent investors backing the company include Life Technologies and NIH SBIR/STTR.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
-
|
Locked | Locked | Locked | |
|
Tools and technologies for biotech and biopharma research were supplied.
|
Locked | Locked | Locked |
Investor details for Compendia Bioscience
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Compendia Bioscience
Investment portfolio details for Compendia Bioscience
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Compendia Bioscience
Detailed financials for Compendia Bioscience
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Compendia Bioscience Comparisons
Peer comparison for Compendia Bioscience
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Compendia Bioscience
Detailed competitors of Compendia Bioscience
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Compendia Bioscience
Complete news archive for Compendia Bioscience
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Compendia Bioscience
Compendia Bioscience was founded in 2006 and raised its 1st funding round 1 year after it was founded.
Compendia Bioscience is headquartered in Ann Arbor, United States. It is registered at Ann Arbor, Michigan, United States.
Compendia Bioscience was founded in 2006 in Ann Arbor, United States, within the bioscience sector. Genomic data and analysis tools are provided for biomarker and gene target identification, primarily in oncology. Operations include web applications such as Oncomine editions for cancer profiling, OncoScore for patient stratification in clinical trials, OncoPredictor tools for biomarker evaluation across preclinical and clinical populations, and solutions for target validation through genomic aberrations and expression analysis.
Compendia Bioscience has 2 investors. Key investors include Life Technologies, and NIH SBIR/STTR.